Different Lipid Emulsions in Acute Lung Injury Patients

NCT01814956 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2016-07-20

No results posted yet for this study

Summary

Aim is to investigate the influence of an early supply of parenteral nutrition including a fish oil containing lipid emulsion on the course of acute lung injury in the intensive care unit. In comparison, a standard parenteral nutrition with a soybean oil based emulsion will be used. Data obtained in this trial may provide evidence for a beneficial effect of fish oil derived omega-3 fatty acids in parenteral nutrition regarding their influence on acute lung injury.

Conditions

  • Parenteral Nutrition

Interventions

DRUG

Lipoplus 20%

Lipoplus 20% (MCT/LCT/FO) i.v. lipid emulsion for parenteral nutrition

DRUG

Lipofundin N 20%

Lipofundin N 20% (LCT, soy bean oil) i.v. lipid emulsion for parenteral nutrition

Sponsors & Collaborators

  • B. Braun Melsungen AG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01814956 on ClinicalTrials.gov